Shares of Ameren Corporation (NYSE:AEE – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty research firms that are currently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $117.95.
Several brokerages have recently commented on AEE. Morgan Stanley upped their target price on Ameren from $108.00 to $109.00 and gave the company an “equal weight” rating in a report on Wednesday, October 21st. Truist Financial dropped their target price on shares of Ameren from $120.00 to $116.00 and set a “buy” rating on the stock in a research report on Wednesday, October 14th. The Goldman Sachs Group reduced their price target on shares of Ameren from $118.00 to $115.00 and set a “neutral” rating for the company in a research report on Thursday, October 15th. BMO Capital Markets raised their price objective on shares of Ameren from $113.00 to $115.00 in a research note on Thursday, October 22nd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Ameren in a research note on Wednesday, November 4th.
Ameren Stock Performance
Shares of NYSE AEE opened at $113.55 on Friday. Ameren has a 12-month low of $96.57 and a 12-month high of $118.32. The company has a market cap of $31.45 billion, a PE ratio of 20.19, a P/E/G ratio of 3.30 and a beta of 0.42. The stock has a 50 day simple moving average of $105.50 and a 200-day simple moving average of $108.72. The company has a current ratio of 0.74, a quick ratio of 0.54 and a debt-to-equity ratio of 1.43.
Ameren (NYSE:AEE – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The utilities provider reported $2.42 EPS for the quarter, topping analysts’ consensus estimates of $2.29 by $0.13. Ameren had a net margin of 17.90% and a return on equity of 11.27%. The company had revenue of $2.88 billion for the quarter, compared to the consensus estimate of $2.82 billion. During the same period in the previous year, the firm earned $2.17 EPS. Ameren’s revenue was up 6.8% on a year-over-year basis. On average, equities research analysts forecast that Ameren will post 5.41 EPS for the current year.
Ameren Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 31st. Shareholders of record on Tuesday, December 8th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Tuesday, December 8th. Ameren’s payout ratio is 52.17%.
Insider Transactions at Ameren
In other Ameren news, Director Rafael Flores sold 248 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $105.53, for a total value of $26,171.44. Following the completion of the sale, the director owned 13,888 shares in the company, valued at $1,465,600.64. This represents a 1.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael L. Moehn sold 6,500 shares of the business’s stock in a transaction on Tuesday, November 3rd. The shares were sold at an average price of $110.72, for a total transaction of $719,680.00. Following the transaction, the insider owned 193,790 shares in the company, valued at approximately $21,456,428.80. This represents a 3.25% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.29% of the stock is owned by corporate insiders.
Institutional Trading of Ameren
Institutional investors have recently bought and sold shares of the company. Droms Strauss Advisors Inc. MO ADV grew its stake in shares of Ameren by 2.2% in the 1st quarter. Droms Strauss Advisors Inc. MO ADV now owns 4,162 shares of the utilities provider’s stock valued at $457,000 after buying an additional 90 shares in the last quarter. Parallel Advisors LLC grew its position in Ameren by 1.6% in the first quarter. Parallel Advisors LLC now owns 5,746 shares of the utilities provider’s stock worth $632,000 after acquiring an additional 93 shares in the last quarter. Cidel Asset Management Inc. increased its stake in shares of Ameren by 5.1% during the 2nd quarter. Cidel Asset Management Inc. now owns 1,990 shares of the utilities provider’s stock worth $225,000 after purchasing an additional 96 shares during the last quarter. IFP Advisors Inc lifted its stake in shares of Ameren by 5.1% in the 3rd quarter. IFP Advisors Inc now owns 2,051 shares of the utilities provider’s stock valued at $204,000 after purchasing an additional 100 shares during the last quarter. Finally, Avidian Wealth Enterprises LLC lifted its stake in shares of Ameren by 1.5% in the 3rd quarter. Avidian Wealth Enterprises LLC now owns 8,212 shares of the utilities provider’s stock valued at $816,000 after purchasing an additional 124 shares during the last quarter. Institutional investors and hedge funds own 79.09% of the company’s stock.
Ameren Company Profile
Ameren Corporation is a regulated utility holding company headquartered in St. Louis, Missouri. Through its subsidiaries, it provides electric and natural gas service to customers across Missouri and Illinois. Ameren Missouri generates, transmits and distributes electricity and delivers natural gas in parts of Missouri. Ameren Illinois operates electric transmission and distribution systems and provides natural gas delivery service in parts of Illinois. The company also develops and operates electric transmission infrastructure.
Featured Stories
- Five stocks we like better than Ameren
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Ameren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameren and related companies with MarketBeat.com's FREE daily email newsletter.
